Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Clinical MedicineIn-Press PreviewEndocrinologyHepatology Open Access | 10.1172/JCI167442

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with non-alcoholic fatty liver

Xiaorong Fu,1 Justin A. Fletcher,1 Stanisław Deja,1 Melissa Inigo-Vollmer,1 Shawn C. Burgess,1 and Jeffrey D. Browning2

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Fu, X. in: JCI | PubMed | Google Scholar |

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Fletcher, J. in: JCI | PubMed | Google Scholar |

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Deja, S. in: JCI | PubMed | Google Scholar |

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Inigo-Vollmer, M. in: JCI | PubMed | Google Scholar |

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Burgess, S. in: JCI | PubMed | Google Scholar

1Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

2Departments of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, United States of America

Find articles by Browning, J. in: JCI | PubMed | Google Scholar

Published March 16, 2023 - More info

J Clin Invest. https://doi.org/10.1172/JCI167442.
Copyright © 2023, Fu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published March 16, 2023 - Version history
View PDF
Abstract

BACKGROUND. Hepatic de novo lipogenesis (DNL) and β-oxidation are tightly coordinated, and their dysregulation is thought to contribute to the pathogenesis of non-alcoholic fatty liver (NAFL). Fasting normally relaxes DNL-mediated inhibition of hepatic β-oxidation, dramatically increasing ketogenesis and decreasing reliance on the TCA cycle. Thus, we tested whether aberrant oxidative metabolism in fasting NAFL subjects is related to the inability to halt fasting DNL.

METHODS. Forty consecutive non-diabetic individuals with and without a history of NAFL were recruited for this observational study. After phenotyping, subjects fasted for 24-hr, and hepatic metabolism was interrogated using a combination of 2H2O and 13C tracers, magnetic resonance spectroscopy, and high-resolution mass spectrometry.

RESULTS. Within a subset of subjects, DNL was detectable after a 24-hr fast and was more prominent in those with NAFL, though it was poorly correlated with steatosis. However, fasting DNL negatively correlated with hepatic β-oxidation and ketogenesis and positively correlated with citrate synthesis. Subjects with NAFL but undetectable fasting DNL (25th percentile) were comparatively normal. However, those with the highest fasting DNL (75th percentile) were intransigent to the effects of fasting on the concentration of insulin, NEFA, and ketones. Additionally, they sustained glycogenolysis and spared the loss of oxaloacetate to gluconeogenesis in favor of citrate synthesis, which correlated with DNL and diminished ketogenesis.

CONCLUSION. Metabolic flux analysis in fasted subjects indicates that shared metabolic mechanisms link the dysregulations of hepatic DNL, ketogenesis, and the TCA cycle in NAFL.

TRIAL REGISTRATION. Data obtained during the enrollment/non-intervention phase of Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease; ClinicalTrials.gov NCT02690792.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (March 16, 2023): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts